GrantExec, a Euna Solutions® company

Grants for County governments - Health

Explore 3,921 grant opportunities

Contraceptive Development Research Centers (P50 Clinical Trial Optional)
$1,300,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 12, 2025

Date Added

Nov 19, 2024

This funding opportunity supports research centers focused on developing innovative contraceptive methods, particularly non-hormonal options, and encourages participation from diverse institutions and underrepresented groups.

Health
State governments
Legal Services for Homeless Veterans and Veterans At-Risk for Homelessness (LSV-H) Grant Program
$500,000
Department of Veterans Affairs (Legal Services for Veterans)
Federal

Application Deadline

Jul 7, 2025

Date Added

Jun 2, 2025

This funding opportunity provides financial support to organizations delivering legal services to homeless veterans and those at risk of homelessness, helping them overcome legal barriers to housing stability.

Law Justice and Legal Services
Nonprofits
BARDA Broad Agency Announcement BAA-23-100-SOL-00004
Contact for amount
Biomedical Advanced Research and Development Authority
Federal

Application Deadline

Not specified

Date Added

Mar 18, 2025

This grant provides funding for organizations to develop and advance medical countermeasures against public health threats, including diseases and emergencies related to chemical, biological, radiological, and nuclear risks.

Health
For profit organizations other than small businesses
Rural Residency Planning and Development Technical Assistance (RRPD-TA) Program
$1,250,000
U.S. Department of Health & Human Services (Health Resources and Services Administration)
Federal

Application Deadline

Mar 18, 2025

Date Added

Jul 15, 2024

This funding opportunity provides financial support and technical assistance to organizations working to establish and sustain residency programs in rural areas, helping to increase the number of physicians in underserved communities.

Health
State governments
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
$459,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 14, 2024

Date Added

Oct 4, 2023

The "Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services" grant aims to fund research that develops and tests new strategies for combining primary care, HIV, Hepatitis, and substance use disorder prevention and treatment services to improve health outcomes for individuals at high risk for or living with these conditions in the US.

Education
State governments
NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 10, 2025

Date Added

Nov 13, 2024

This funding opportunity supports researchers in conducting early-stage clinical trials for innovative treatments and interventions targeting neurological disorders.

Health
State governments
Haywood County Community Foundation Grant Program
$1,000
Haywood County Community Foundation
Private

Application Deadline

Aug 6, 2024

Date Added

Jul 22, 2024

The Haywood County Community Foundation is accepting applications from qualified charitable organizations that serve the local Haywood County community in North Carolina. This grant program is designed to address a broad range of local needs, encompassing human services, education, youth development, health, food/nutrition, and arts, among others. The foundation's mission, as evidenced by this grant, is to support community-based initiatives that enhance the well-being and development of its residents. The target beneficiaries of this grant are the residents of Haywood County, with a particular focus on those served by 501(c)(3) public charity nonprofit organizations, local governments (including public schools), fire and rescue departments, and religious entities engaged in social outreach and charitable service programs. The impact goal is to strengthen the community by funding programs that directly meet local needs and improve the quality of life for its citizens. The grantmaking prioritizes a wide array of community needs. While specific strategic priorities or a theory of change are not explicitly detailed beyond meeting "local needs," the broad categories indicate a holistic approach to community development. The foundation aims to fund projects that are inclusive and non-discriminatory, supporting organizations that offer programs and services without prejudice based on age, race, national origin, ethnicity, gender, physical ability, sexual orientation, political affiliation, or religious belief. Grants typically range from $500 to $1,000, suggesting a focus on supporting smaller, impactful projects or providing seed funding for broader initiatives. While specific measurable results are not outlined in the provided text, the expectation is that funded programs will contribute to positive outcomes in the community, aligned with the stated areas of focus such as improved human services, enhanced educational opportunities, better health outcomes, and increased access to food and nutrition. The emphasis on local needs implies a theory of change where targeted, community-level funding leads to tangible improvements in the daily lives of Haywood County residents.

Education
Nonprofits
NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
$500,000
U.S. Departmentof Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 6, 2025

Date Added

Dec 19, 2024

This funding opportunity provides financial support for early-stage researchers from diverse backgrounds to conduct independent studies on communication disorders, including hearing and speech issues, with a focus on addressing significant scientific and clinical challenges.

Health
State governments
Advancing national epidemiologic, surveillance, research and laboratory capacities and systems to support a sustainable and resilient response to HIV/TB and related public health threats in the Kingdom of Eswatini under PEPFAR
$5,500,000
U.S. Department of Health & Human Services (Centers for Disease Control-GHC)
Federal

Application Deadline

Mar 5, 2025

Date Added

Jul 19, 2024

This funding opportunity provides financial support to organizations working with the Eswatini government to strengthen public health systems for monitoring and responding to HIV, TB, and related health threats.

Health
State governments
Notice of Intent to Publish a Funding Opportunity Announcement for Viral INfections in the Young Lung- The VINYL Clinical Consortium (UG3/UH3 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 13, 2025

Date Added

Sep 27, 2024

This funding opportunity is designed to support research initiatives that will study and track the long-term effects of severe viral respiratory infections in young children, aiming to improve their health outcomes as they grow.

Health
State governments
Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 5, 2024

Date Added

Dec 13, 2023

This funding opportunity supports researchers in developing small molecule chemical probes to investigate biological processes related to mental health, aging, drug addiction, and eye diseases.

Education
State governments
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional (R01 Clinical Trial Not Allowed)
$350,000
U.S. Department of Health and Human Services - National Institutes of Health
Federal

Application Deadline

Aug 13, 2024

Date Added

Sep 21, 2023

The purpose of this initiative is to: 1.Support mining of SCORCH data to identify cell types, transcripts, enhancers, or transcriptional networks that play a role in HIV/ART or SUD molecular responses 2.Support functional validation studies (e.g. epigenomic or transcriptomic manipulation, high throughput secondary screening, etc.) to confirm or deny a biological role for data-mined cell types, transcripts, enhancers, or transcriptional networks in HIV/ART or SUD molecular responses 3.Provide foundational knowledge for understanding SUD and/or HIV/ART molecular mechanisms and to generate validated targets that could serve as a foundation for new SUD or HIV therapeutics (including NeuroHIV cognitive phenotypes)

Education
State governments
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 25, 2024

Date Added

Mar 20, 2024

This funding opportunity supports innovative research to measure brain changes over time in people of all ages, including those with cognitive or emotional challenges, to better understand brain development and aging.

Education
State governments
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
$1,700,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 21, 2025

Date Added

Feb 12, 2025

This funding opportunity supports partnerships between institutions serving underserved populations and cancer research centers to improve cancer research, education, and outreach initiatives aimed at reducing health disparities.

Education
State governments
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
$250,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 15, 2024

Date Added

Jun 5, 2025

This funding opportunity supports researchers and institutions in validating high-quality biomarkers and assays for cancer detection, diagnosis, and treatment monitoring, facilitating their integration into clinical studies.

Education
State governments
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 3, 2025

Date Added

Aug 9, 2023

This funding opportunity supports experienced laboratory scientists engaged in cancer research within NCI-funded projects, providing salary support and travel funds to enhance their contributions without requiring them to become independent investigators.

Education
State governments
Rural Mental Health Initiative Grant Program
$250,000
Texas Health and Human Services Commission
State

Application Deadline

Jul 3, 2024

Date Added

Jun 12, 2024

The Texas Health and Human Services Commission (HHSC), the System Agency, is accepting Applications for the Rural Mental Health Initiative Grant Program (RIGP) as directed by Senate Bill 1677, 88th Legislature, Regular Session, 2023. Through the Rural Mental Health Initiative Grant Program, HHSC will award grants to Rural serving Local Mental Health Authorities (LMHAs), Local Behavioral Health Authorities (LBHAs), nonprofit organizations, or governmental entities to be matched in accordance with the specifications outlined in Section 5.4., to address the mental health needs of individuals with mental illness or serious emotional disturbance residing in Rural Texas in accordance with the specifications contained in this Request for Application.

Law Justice and Legal Services
Nonprofits
Notice of Intent to Publish a Funding Opportunity Announcement for Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
$400,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 28, 2025

Date Added

Nov 26, 2024

This funding opportunity provides financial support for early-career researchers in genomics to advance innovative projects that contribute to the field and promote diversity within the research community.

Health
State governments
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
$100,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

May 7, 2024

Date Added

May 12, 2020

The primary purpose of the NIH Mentored Clinical Scientist Research Career Development Awards (K08) program is to prepare qualified individuals for careers that have a significant impact on the health-related research needs of the Nation. This program represents the continuation of a long-standing NIH program that provides support and "protected time" to individuals with a clinical doctoral degree for an intensive, supervised research career development experience in the fields of biomedical and behavioral research, including translational research.

Education
State governments
Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed)
$500,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 10, 2024

Date Added

Mar 14, 2024

Notice of Funding Opportunity Description Background The accumulation of misprocessed and aberrant proteins is a defining characteristic of various neurodegenerative conditions, such as AD and frontotemporal lobar degeneration (FTLD). These atypical proteins may arise from various factors, such as somatic mutations, environmental changes, genomic instability, irregular RNA processing, and proteolytic cleavages, as well as incorrect folding and post-translational modifications. For instance, many recent proteome and transcriptome profiling of AD brains reveals RNA splicing dysfunction and abnormal accumulation of U1 small nuclear ribonucleoprotein (snRNP) and transactive response DNA-binding protein 43 (TDP-43). In AD, U1-70K and its N-terminal 40-KDa fragment (N40K) is one of the most abundant proteins in the insoluble fraction of cell lysates. TDP-43 is an RNA-binding protein. In AD, TDP-43 pathology is observed in approximately 25-50% of cases, particularly in cases with co-morbidities such as Lewy body dementia or hippocampal sclerosis. However, the relationship between U1snRNP/TDP-43 and AD pathology is complex and not fully understood. The disruption of RNA processing is thought to be one possible mechanism to cause the accumulation of misprocessed proteins, which can lead to altered expression of genes involved in AD pathology, including amyloid precursor protein (APP), tau, and synaptic proteins. Understanding the mechanisms underlying the dysregulation of misprocessed proteins in neurodegenerative diseases will be important for developing effective therapies. Approaches that target the production or aggregation of misprocessed proteins, or that promote their clearance or degradation, may be effective in preventing or slowing disease progression. Purpose This NOFO invites innovative research proposals to explore the accumulation of misprocessed proteins in Tauopathies within specific brain regions and cell types. This NOFO encourages collaborative efforts to create advanced single-cell or single-cell type proteogenomic platforms. These platforms aim to shed light on dynamic changes in protein-misfolding responses in neuronal proteomes and their potential biological consequences during aging and the development of AD/ADRD. Research Objectives This NOFO aims to provide a proof-of-principal for a novel strategy to identify misprocessed and aberrant proteins in Tau diseases using the proteogenomic approach. Proteogenomics is an integrated approach that combines proteomics and genomics data. In proteogenomics, genomic and transcriptomic experiments are more closely integrated to identify potential protein coding and non-coding regions in the genome. These regions are then validated using mass spectrometry-based proteomics. Proteogenomics has emerged as a powerful tool for investigating the role of protein homeostasis in AD pathogenesis, especially in the context of mis-translated and mis-repaired proteins. However, relying solely on misprocessed protein levels to draw conclusions about biological processes is unlikely to be reliable. Therefore, an intermediate layer of functional validation is essential to transform proteogeomic data into meaningful biological information. As a result, the objective of this NOFO is not only to confirm changes in protein abundance using other methods, but also to assess the biological effects of those changes in some model systems, especially in the area of tauopathies, to ensure high interlaboratory reproducibility. Using the proteogenomics approach, this NOFO aims to accomplish the following: Create a comprehensive database of misprocessed and aberrant proteins in selected mouse models of human Tau diseases. Cross-validate the presence of misprocessed and aberrant proteins in human AD/ADRD brains. Identify new molecular pathways and novel misprocessed protein-protein interaction networks that are not currently in most datasets. Define novel mechanisms through which misprocessed and aberrant proteins influence the onset and progression of neurodegeneration in tauopathies. Identify disease specific therapeutic targets in neurodegenerative diseases. It is expected that applications responding to this initiative will use the latest cell-type-specific labeling and proteogenomic techniques with suitable model systems to understand the etiology of tauopathies in aging and AD.

Health
State governments